News

Silent MI More Common Than Suspected; FDA Approves First A1C Test for Diagnosing Diabetes; Cash Back for Eating Better; Counting the Real Calories

Silent myocardial infarction (MI) has been a clinical mystery. The lack of unequivocal signs and symptoms makes silent MI hard to diagnose, which means the prevalence is also hard to determine. Moreover, say researchers from University Hospital Basel in Switzerland, silent MIs represent "missed opportunities" to start at-risk patients on statins and other preventive therapies.


 

Recommended Reading

Joint Injections Don't Raise Bleeding Risk
Federal Practitioner
Heparin-Induced Thrombocytopenia: References
Federal Practitioner
Heparin-Induced Thrombocytopenia: Presentation and History
Federal Practitioner
QT Alert Helps Save Lives; An Underrecognized Complication of Sickle Cell Disease
Federal Practitioner
Controlling Hypertension
Federal Practitioner
ICD Shocks: Which Comes First, the Shock or the Anxiety?; Understanding Self-Harm; The Link Between C-Reactive Protein and Low Back Pain
Federal Practitioner
Gel Implant Relieves Sciatica; Antidepressants for Heart Failure Patients—Are There Benefits?; Chelation: Long Established, but Is It Safe?
Federal Practitioner
Leukocytosis After ICD Implantation; A Misleading Case of Herpes; Calculating the Risks of C difficile; Keeping Weight Off: A Losing Battle?
Federal Practitioner
Sleep Disorder Plus Diabetes Equals Cardiac Events?
Federal Practitioner
Competing Cardiovascular Outcomes
Federal Practitioner